Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multi-Centre, Two-Arm, Interventional, Phase IV Study to Evaluate Tailoring of Recombinant FSH Treatment in Subjects with Chronic Anovulation Using the Gonal-f Prefilled Pen in Women Undergoing Ovulation Induction

Trial Profile

A Multi-Centre, Two-Arm, Interventional, Phase IV Study to Evaluate Tailoring of Recombinant FSH Treatment in Subjects with Chronic Anovulation Using the Gonal-f Prefilled Pen in Women Undergoing Ovulation Induction

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Follitropin alfa (Primary)
  • Indications Polycystic ovary syndrome
  • Focus Therapeutic Use
  • Acronyms LoGo
  • Sponsors Merck KGaA; Merck Serono

Most Recent Events

  • 30 Jun 2016 Status changed from completed to discontinued because of delays in sourcing replacement Investigational Medicinal Product for the study due to manufacturing delays
  • 20 Nov 2014 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network.
  • 29 Apr 2014 According to the ClinicalTrials.gov record, Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top